Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Journal of Inflammation
- Vol. 5 (1) , 4
- https://doi.org/10.1186/1476-9255-5-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Etanercept for Crohn's DiseaseNew England Journal of Medicine, 2004
- Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyArthritis & Rheumatism, 2004
- Pulmonary Cryptococcosis After Initiation of Anti-Tumor Necrosis Factor-α TherapyChest, 2003
- Disseminated Sporotrichosis Associated with Treatment with Immunosuppressants and Tumor Necrosis Factor–α AntagonistsClinical Infectious Diseases, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialPublished by Elsevier ,2002
- Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor AntagonistsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Treatment of Rheumatoid Arthritis by TNF-Blocking AgentsInternational Archives of Allergy and Immunology, 2002
- Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2001
- Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient miceGastroenterology, 1994